Valley Forge Asset Management’s GSK GSK Stock Holding History

Valley Forge Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$512K	Buy	10,144 +460	+5%	+$23.4K	0.08%	73
2015 Q3	$465K	Sell	9,684 -80	-0.8%	-$4.16K	0.07%	72
2015 Q2	$508K	Sell	9,764 -400	-4%	-$22.5K	0.07%	78
2015 Q1	$586K	Buy	10,164 +1,120	+12%	+$64.2K	0.07%	69
2014 Q4	$483K	Sell	9,044 -201,951	-96%	-$11.3M	0.06%	74
2014 Q3	$12.1M	Buy	210,995 +6,116	+3%	+$375K	1.48%	33
2014 Q2	$13.7M	Sell	204,879 -6,329	-3%	-$428K	1.47%	38
2014 Q1	$14.1M	Sell	211,208 -7,578	-3%	-$512K	1.52%	33
2013 Q4	$14.6M	Sell	218,786 -167,078	-43%	-$10.8M	1.41%	33
2013 Q3	$24.2M	Sell	385,864 -16,986	-4%	-$1.09M	1.6%	28
2013 Q2	$25.2M	Buy	+402,850	New	+$25.6M	1.65%	30

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Valley Forge Asset Management's GSK Position: Q4 2015 in Review

Valley Forge Asset Management increased its GSK (GSK) stake by 4.8% in Q4 2015, buying an estimated $23.4K and bringing the position to 10,144 shares worth $512K. The position accounts for 0.08% of the portfolio, ranked #73.

Valley Forge Asset Management first reported a position in GSK in Q2 2013 and has held it in 11 quarters since. The position peaked at $25.2M in Q2 2013. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Valley Forge Asset Management held 10,144 shares of GSK worth $512K as of Q4 2015.
Valley Forge Asset Management bought 460 GSK shares in Q4 2015, an estimated $23.4K.
GSK made up 0.08% of Valley Forge Asset Management's portfolio in Q4 2015, its #73 holding.
Valley Forge Asset Management first reported a position in GSK in Q2 2013 and has held it in 11 quarters since.
Valley Forge Asset Management's GSK position peaked at $25.2M in Q2 2013.
718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Valley Forge Asset Management's 13F filing for Q4 2015, filed 9 Feb 2016.